⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TVTX News
Travere Therapeutics, Inc. Common Stock
Travere Therapeutics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation
accessnewswire.com
TVTX
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
globenewswire.com
TVTX
SHAREHOLDER ALERT: Travere Therapeutics, Inc. Investigated for Securities Fraud by Block & Leviton; Investors Who Lost Money Should Contact The Firm
globenewswire.com
TVTX
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI ® (sparsentan) in FSGS
businesswire.com
TVTX
Travere Therapeutics Provides Corporate Update and 2026 Outlook
businesswire.com
TVTX
Travere Therapeutics to Present at the 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
TVTX
Travere Therapeutics Announces Late-Breaking Data from Phase 3 DUPLEX Study of FILSPARI in FSGS Presented at the American Society of Nephrology (ASN) Kidney Week 2025
businesswire.com
TVTX
Travere Therapeutics to Participate at Upcoming Investor Conferences
businesswire.com
TVTX
Travere Therapeutics Reports Third Quarter 2025 Financial Results
businesswire.com
TVTX